Rocket Pharmaceuticals Inc.
RCKT | NASDAQ
$3.27
-$0.10 (-2.97%)
At close: Sep 21, 2026, 4:00 PM ET
$3.27
$0 (0.00%)
Pre-market:
Sep 22, 2026, 4:52 AM ET
Market Data
Market Cap $367.98M
Enterprise Value $157.35M
Beta 0.50
Average Volume 2.13M
Shares Outstanding (Diluted) 114.51M
Shares Change YoY 3.15%
Institutional Ownership 86.68%
Exchange NASDAQ
ISIN US77313F1066
Price Performance
Price Change 1M -7.4%
Price Change 3M -5.8%
Price Change 6M -30.1%
Price Change YTD -5.5%
Price Change 1Y 2.8%
Price Change 3Y -84.0%
Price Change 5Y -89.8%
1M CAGR (ann.) -4.8%
1Y CAGR (ann.) 11.2%
5Y CAGR (ann.) -37.5%
All-Time CAGR -15.6%
Valuation
PE Ratio -19.24
Forward PE N/A
PEG Ratio -0.14
Forward PEG -0.02
PS Ratio N/A
Forward PS 31.70
PB Ratio 0.97
P/FCF Ratio -2.10
P/Adj. FCF Ratio -1.77
P/OCF Ratio -2.17
EV/Sales N/A
EV/EBIT -40.34
EV/EBITDA 19.79
EV/FCF -0.92
Earnings Yield -5.2%
FCF Yield -47.7%
Adj. FCF Yield -56.6%
Financial Health
Net Cash $199.71M
Total Debt $24.8M
Cash & Short-Term Investments $224.51M
Total Assets $423.1M
Current Ratio 9.24
Quick Ratio 9.24
Debt / Equity Ratio 0.07
Debt / EBITDA 3.12
Debt / FCF -0.15
OCF / Debt -6.87
Interest Coverage -40.53
Altman Z-Score 0.25
Piotroski F-Score 2
Margins & Profitability
Gross Profit Margin 0.0%
Operating Profit Margin 0.0%
EBITDA Margin 0.0%
Net Profit Margin 0.0%
FCF Margin N/A
Adj. FCF Margin N/A
SBC / Revenue 0.0%
SBC Impact (per share) -18.6%
Returns
Return on Assets -4.1%
Return on Equity -5.8%
Return on Invested Capital -48.5%
Return on Capital Employed -48.9%
Return on Tangible Assets -4.8%
Historical Growth (CAGR)
Revenue CAGR 3Y N/A
Revenue CAGR 5Y N/A
Revenue CAGR 10Y N/A
EPS CAGR 3Y 71.8%
EPS CAGR 5Y 27.2%
EPS CAGR 10Y 10.1%
FCF CAGR 3Y 10.3%
FCF CAGR 5Y -1.7%
FCF CAGR 10Y -16.1%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 19
EPS Growth Next 3Y -122.9%
Revenue Growth Next 3Y N/A
Earnings Date Nov 4, 2026
EPS Estimate (next Q) -$0.39
EPS Growth Est (next Q) -13.3%
Revenue Est (next Q) $200K
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $9
Price Target Upside 175.2%
Cash Flow
Operating Cash Flow $-170.28M
Free Cash Flow $-170.4M
Adj. Free Cash Flow $-202.19M
FCF Per Share -$1.51
OCF Per Share -$1.51
OCF/S Ratio 0.0%
Income Statement
Revenue $0
Gross Profit $-2.15M
Operating Income $-191.64M
EBITDA $7.95M
Net Income $-17.25M
EPS (Diluted) -$0.17
Revenue / Employee N/A
Profit / Employee $-85.4K
Employees 202
Add to Watchlist
Select watchlists to add or remove RCKT